XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands, € in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Cash flows from operating activities:    
Net income $ 9,739 $ 4,858
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,777 3,016
Loss (Gain) on disposal of property, plant & equipment 1 (12)
Share-based compensation 1,056 692
Change in fair value of contingent consideration 2,853 0
Deferred income taxes (545) (440)
Changes in operating assets and liabilities:    
Receivables, net (4,863) (4,467)
Inventories (3,054) (7,826)
Prepaid expenses and other current assets (377) (1,712)
Other assets (1,850) 308
Accounts payable 65 4,105
Accrued expenses (6,197) (3,365)
Deferred revenue (1,098) 793
Income taxes payable 2,765 1,130
Non-qualified deferred compensation plan and other liabilities 451 (296)
Net cash provided by (used in) operating activities 1,723 (3,216)
Cash flows from investing activities:    
Additions to property, plant, and equipment (2,179) (2,334)
Proceeds from sale of fixed assets 2 12
Net cash used in investing activities (2,177) (22,975)
Cash flows from financing activities:    
Proceeds from advances on revolving line of credit 6,000 28,000
Payments on revolving line of credit 0 (7,000)
Principal payments of long-term debt (1,000) (1,000)
Principal payments on finance lease obligations (16) (16)
Proceeds from the exercise of stock options 109 0
Payment of statutory withholdings for restricted stock units vested (2,522) (1,299)
Net cash provided by financing activities 2,571 18,685
Effect of foreign currency exchange rates on cash and cash equivalents (65) 41
Net increase (decrease) in cash and cash equivalents 2,052 (7,465)
Cash and cash equivalents at beginning of period 4,451 11,117
Cash and cash equivalents at end of period 6,503 3,652
Advant Medical [Member]    
Cash flows from investing activities:    
Acquisition, net of cash acquired 0 (20,768)
DAS Medical [Member]    
Cash flows from investing activities:    
Acquisition, net of cash acquired $ 0 $ 115